Research and development - Press Releases

Date	Title	Company
18-Jul-2023	Lifebit partners with Latin American innovators to help solve global health challenges through genomics research	Lifebit
18-Jul-2023	Mainz Biomed Announces Collaboration with Fugene Genetics in Israel	Mainz Biomed
18-Jul-2023	Elevar Therapeutics Announces FDA Acceptance for Filing of New Drug Application for Rivoceranib in Combination with Camrelizumab as a First-line Treatment for Unresectable Hepatocellular Carcinoma	Elevar Therapeutics
18-Jul-2023	Full Spectrum Integration: CD Formulation’s All-encompassing Solutions for Cosmetic Products	CD Formulation
17-Jul-2023	Alfa Chemistry: Custom Design Takes Organs-On-Chips to the Next Level	Alfa Chemistry
17-Jul-2023	Alfa Chemistry Newly Launches Proteomic Products for Life Science and Analytical Research	Alfa Chemistry
13-Jul-2023	Landmark study demonstrates economic edge of precision medicine that we can’t afford to ignore	Diaceutics Plc
13-Jul-2023	New Business Support Programme and Competition for Life Science Startups - Discovery Spark	Discovery Park
12-Jul-2023	Vivan Therapeutics, the Institute for Cancer Research and IDIBELL form new AI drug discovery collaboration to design new precision cancer drugs	Vivan Therapeutics
11-Jul-2023	Kindeva Drug Delivery, Chiesi Group, and H&T Presspart Announce Strategic Partnership for Dose Counter Technology Production	Kindeva Drug Delivery
11-Jul-2023	Sosei Heptares Webinar Presentation for Q2 FY2023 Financial Results	Sosei Group Corporation
11-Jul-2023	KFSH&RC Implants Brain Electrodes in Child to Detect Epileptic Foci Without Surgery for First Time in Middle East	King Faisal Specialist Hospital and Research Center (KFSH&RC)
11-Jul-2023	Eremid® Genomic Services expands long-read HiFi sequencing capabilities with PacBio Revio	Eremid® Genomic Services
11-Jul-2023	Rapid UTI test launched after new figures reveal eight million hours wasted on GP visits costing the NHS nearly £300m every year	newfoundland
11-Jul-2023	Sequana Medical announces first patient enrolled in MOJAVE, a US randomized controlled Phase 1/2a study of DSR® 2.0 for treatment of congestive heart failure	Sequana Medical
11-Jul-2023	Recommendations from Imperial College London to improve UK’s competitiveness in critical industries	Imperial College London
10-Jul-2023	Domainex expands its research operations by securing from Howard Group a new facility at Unity Campus	Sciad Newswire
07-Jul-2023	Alfa Chemistry: Environmental Standards to Achieve Fast and Accurate Environmental Analysis	Alfa Chemistry
06-Jul-2023	Qkine and Sartorius Partnership Delivers a Complete Workflow Solution for the Analysis of Advanced Cell Models	Qkine
06-Jul-2023	1,000th alfapump® implant completed	Sequana Medical NV